Thermage vs Ultherapy: RF Skin Tightening vs MFU-V Lifting

Thermage uses monopolar radiofrequency to heat the dermis and produce controlled dermal heating. Ultherapy uses microfocused ultrasound at selectable 1.5, 3.0 and 4.5 mm focal depths; the deepest setting can reach the SMAS. Their treated planes can overlap, so device choice or combination requires examination rather than a simple “surface versus deep” rule. The cited studies used different devices, designs and follow-up periods, so they do not establish the same fixed duration for both treatments (Alam et al., 2010; Suh et al., 2011).

The most common comparison in non-surgical skin tightening is between Thermage and Ultherapy. They are not interchangeable devices. They use different energy sources, they heat different layers of tissue, they produce different clinical results, and they are appropriate in different patient profiles. The decision between them, or whether to do both, is a clinical question, not a marketing one, and the clinical evidence on each device sits in different parts of the dermatology and plastic surgery literature.

The core mechanical difference

Thermage uses monopolar capacitive radiofrequency. The energy is electrical, it warms tissue by oscillating polar molecules in an alternating electric field, and at therapeutic settings it heats the dermal layer of the skin (Fritz, Counters & Zelickson, 2004; Dover & Zelickson, 2007). Ultherapy uses microfocused ultrasound with visualisation, abbreviated MFU-V. The energy is acoustic, it deposits focal heat at depths set by the transducer (1.5, 3.0 or 4.5 mm), and the deepest setting can place that energy into the superficial musculoaponeurotic system (the SMAS), the fibrous layer a plastic surgeon mobilises during a facelift. The first published rater-blinded cohort on the Ultherapy mechanism (Alam et al., 2010) established the clinical effect on facial and neck skin; subsequent Korean cohorts confirmed comparable effect in Asian skin (Suh et al., 2011).

Side-by-side comparison

Reading the table: anatomy matters more than age

Age alone does not determine the device. A person with predominantly dermal laxity or a skin-firmness concern may discuss monopolar RF, while a person whose examination supports treatment at one or more MFU-V focal planes may discuss Ultherapy. Either pattern can occur at different ages, and neither can be diagnosed from a marketing table.

The examination should consider skin thickness, the location and degree of laxity, prior procedures, tissue volume and treatment goals. Ultherapy is not only a 4.5 mm SMAS treatment: its 1.5 and 3.0 mm transducers also create focal thermal coagulation points at shallower planes.

A patient with body-area laxity, whether abdominal skin after weight loss or post-pregnancy, inner arms, knees or inner thighs, is a Thermage question. Ultherapy is not designed for body work; the transducer depth options and the lifting mechanism are face-and-neck oriented. Thermage body tips are designed for the larger surface and the higher pulse counts these areas need.

When to combine Thermage and Ultherapy

Combination is not automatic. Because the energy patterns and treated planes can overlap, the clinician must decide whether using both adds a distinct benefit for the individual rather than duplicating treatment. Published evidence for each device does not by itself prove that a combined protocol is superior.

Combining is a clinical decision, not a default. It is appropriate when the laxity profile shows both layers contributing to the result the patient wants; it is not appropriate when one layer dominates and the second device would add cost without adding clinical value. A consultation with the parent clinic discusses this directly — see Delight Dermatology's Thermage and Ultherapy combination consultation for the combined Thermage and Ultherapy plan options.

What neither device does

Neither device produces a permanent result. Neither replaces a surgical lift when laxity is severe. Neither eliminates wrinkles in the way a filler or a botulinum toxin does. There are no claims here of being the best or the world-class clinic for either treatment, and there are no guarantees of result; both devices have a clinical effect that varies between patients and that is reasonable to expect, not to promise.

Researching the other side of this comparison? Our sister specialty site explains what Ultherapy is and how its 1.5, 3.0 and 4.5 mm transducers create focal treatment planes in equivalent depth.